OBJECTIVE - This study examined the metabolic effects of heart transplantation in patients in end-stage cardiac failure. RESEARCH DESIGN AND METHODS - A total of 18 patients after heart transplantation for end-stage heart disease (age 47 ± 3 years; transplant age 5.5 ± 1.5 years; BMI 25.8 ± 0.8 kg/m2; cyclosporin A 4.2 ± 0.6 mg/[kg·day]; azathioprine 0.87 ± 0.31 mg/[kg·day]), 12 patients with type 2 diabetes (D-Tx), and 6 patients without type 2 diabetes (Tx) were studied by means of 1) an oral glucose tolerance test (OGTT) to assess the β-cell secretory response, 2) a euglycemic-hyperinsulinemic (1 mU/[kg·min]) clamp combined with indirect calorimetry and a primed continuous infusion of [6,6-2H2]glucose and [1- 13C]leucine to measure postabsorptive and insulin-stimulated carbohydrate and protein metabolism, and 3) 1H-NMR spectroscopy of the calf muscles to measure intramyocellular triglyceride (IMCL) content. The patients were selected from 480 transplant patients in whom there was a 6% prevalence of type 2 diabetes. Five healthy subjects matched for anthropometric parameters served as control subjects (CON). RESULTS - Tx had postabsorptive and insulin-stimulated glucose, leucine, and free fatty acid metabolism, as well as IMCL content, similar to that of CON. D-Tx were characterized by a reduced secretory response during the OGTT and peripheral insulin resistance with respect to glucose metabolism, which was paralleled by increased plasma free fatty acid concentrations and IMCL content. A defective insulin-dependent suppression of the endogenous leucine flux (index of proteolysis) was also evident during the clamp in D-Tx. CONCLUSIONS - Heart transplantation, notwithstanding the immunosuppressive therapy, was characterized by a normal postabsorptive and insulin-stimulated glucose, leucine, and free fatty acid metabolism in Tx. In contrast, insulin resistance with respect to glucose, free fatty acids, and protein metabolism was present in D-Tx regardless of whether diabetes was preexisting or consequent to heart transplantation

Benedini, S., Fiocchi, R., Battezzati, A., Scifo, P., Sereni, L., Gamba, A., et al. (2002). Energy metabolism in diabetic and nondiabetic heart transplant recipients. DIABETES CARE, 25(3), 530-536 [10.2337/diacare.25.3.530].

Energy metabolism in diabetic and nondiabetic heart transplant recipients

SCIFO, PAOLA VITTORIA;PERSEGHIN, GIANLUCA
Penultimo
;
2002

Abstract

OBJECTIVE - This study examined the metabolic effects of heart transplantation in patients in end-stage cardiac failure. RESEARCH DESIGN AND METHODS - A total of 18 patients after heart transplantation for end-stage heart disease (age 47 ± 3 years; transplant age 5.5 ± 1.5 years; BMI 25.8 ± 0.8 kg/m2; cyclosporin A 4.2 ± 0.6 mg/[kg·day]; azathioprine 0.87 ± 0.31 mg/[kg·day]), 12 patients with type 2 diabetes (D-Tx), and 6 patients without type 2 diabetes (Tx) were studied by means of 1) an oral glucose tolerance test (OGTT) to assess the β-cell secretory response, 2) a euglycemic-hyperinsulinemic (1 mU/[kg·min]) clamp combined with indirect calorimetry and a primed continuous infusion of [6,6-2H2]glucose and [1- 13C]leucine to measure postabsorptive and insulin-stimulated carbohydrate and protein metabolism, and 3) 1H-NMR spectroscopy of the calf muscles to measure intramyocellular triglyceride (IMCL) content. The patients were selected from 480 transplant patients in whom there was a 6% prevalence of type 2 diabetes. Five healthy subjects matched for anthropometric parameters served as control subjects (CON). RESULTS - Tx had postabsorptive and insulin-stimulated glucose, leucine, and free fatty acid metabolism, as well as IMCL content, similar to that of CON. D-Tx were characterized by a reduced secretory response during the OGTT and peripheral insulin resistance with respect to glucose metabolism, which was paralleled by increased plasma free fatty acid concentrations and IMCL content. A defective insulin-dependent suppression of the endogenous leucine flux (index of proteolysis) was also evident during the clamp in D-Tx. CONCLUSIONS - Heart transplantation, notwithstanding the immunosuppressive therapy, was characterized by a normal postabsorptive and insulin-stimulated glucose, leucine, and free fatty acid metabolism in Tx. In contrast, insulin resistance with respect to glucose, free fatty acids, and protein metabolism was present in D-Tx regardless of whether diabetes was preexisting or consequent to heart transplantation
Articolo in rivista - Articolo scientifico
Endocrinology, Diabetes and Metabolism; Internal Medicine
English
2002
25
3
530
536
reserved
Benedini, S., Fiocchi, R., Battezzati, A., Scifo, P., Sereni, L., Gamba, A., et al. (2002). Energy metabolism in diabetic and nondiabetic heart transplant recipients. DIABETES CARE, 25(3), 530-536 [10.2337/diacare.25.3.530].
File in questo prodotto:
File Dimensione Formato  
DCare-02.pdf

Solo gestori archivio

Dimensione 152 kB
Formato Adobe PDF
152 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/165296
Citazioni
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
Social impact